title: MPTP-induced deficits in striatal synaptic plasticity are prevented by glial cell line-derived neurotrophic factor expressed via an adeno-associated viral vector.
abstract: This study determined the consequences of dopamine denervation of the striatum on synaptic plasticity and prevention of these changes with gene therapy using an adeno-associated viral vector (AAV) expressing glial cell line-derived neurotrophic factor (GDNF). C57BL6/J mice were injected with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP); long-term depression (LTD) or potentiation (LTP) were measured in vitro. Fast-scan cyclic voltammetry measured electrically released dopamine from a functionally relevant pool in these same striatal slices. After MPTP, dopamine release and uptake were greatly diminished, and LTP and LTD were blocked in the striatal slices. The loss of plasticity resulted directly from the loss of dopamine since its application rescued synaptic plasticity. Striatal GDNF expression via AAV, before MPTP, significantly protected against the loss of dopamine and prevented the blockade of corticostriatal LTP. These data demonstrate that dopamine plays a role in supporting several forms of striatal plasticity and that GDNF expression via AAV prevents the loss of dopamine and striatal plasticity caused by MPTP. We propose that impairment of striatal plasticity after dopamine denervation plays a role in the symptomology of Parkinson's disease and that AAV expression of neurotrophic factors represents a tenable approach to protecting against or slowing these neurobiological deficits.
authors: Program of Clinical Medicine, Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan, ROC.
authors: Yuan-Hao
authors: YH
authors: Chen
authors: Brandon K
authors: BK
authors: Harvey
authors: Alexander F
authors: AF
authors: Hoffman
authors: Yun
authors: Y
authors: Wang
authors: Yung-Hsiao
authors: YH
authors: Chiang
authors: Carl R
authors: CR
authors: Lupica
mesh_terms: D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000494:pharmacology*; D000200:Action Potentials; D000818:Animals; D003342:Corpus Striatum / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D000229:Dependovirus / Q000235:genetics*; D004298:Dopamine / Q000378:metabolism; D004563:Electrochemistry; D005822:Genetic Vectors; D051100:Glial Cell Line-Derived Neurotrophic Factor / Q000235:genetics / Q000494:pharmacology*; D051379:Mice; D008810:Mice, Inbred C57BL; D009473:Neuronal Plasticity / Q000187:drug effects*; D011994:Recombinant Proteins / Q000235:genetics / Q000494:pharmacology
chemical_list: D051100:Glial Cell Line-Derived Neurotrophic Factor; D011994:Recombinant Proteins; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D004298:Dopamine
references: Pharmacol Biochem Behav. 2004 May;78(1):143-53
references: 15159144
references: Nat Med. 2003 May;9(5):589-95
references: 12669033
references: Brain Res. 2000 Oct 20;881(1):69-72
references: 11033095
references: J Neurosci. 2005 Jan 26;25(4):769-77
references: 15673656
references: Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):1255-60
references: 11158626
references: Nature. 1995 Jan 26;373(6512):335-9
references: 7830766
references: Science. 2000 Oct 27;290(5492):767-73
references: 11052933
references: J Virol. 2002 Jan;76(2):791-801
references: 11752169
references: J Virol. 1998 Mar;72(3):2224-32
references: 9499080
references: Nature. 1979 Jan 11;277(5692):93-6
references: 215920
references: J Neurosci. 2003 Jun 15;23(12):4815-20
references: 12832502
references: Neurosci Lett. 1990 Jul 31;115(2-3):248-52
references: 1978265
references: J Neurophysiol. 2001 Jan;85(1):117-24
references: 11152712
references: Eur J Neurosci. 1993 Feb 1;5(2):107-17
references: 7903183
references: Trends Neurosci. 2003 Apr;26(4):184-92
references: 12689769
references: Neurotoxicology. 2005 Oct;26(5):779-83
references: 15927256
references: Neurobiol Dis. 2007 Jul;27(1):67-76
references: 17532642
references: Science. 1997 Feb 7;275(5301):838-41
references: 9012352
references: Brain Res. 1993 Aug 13;619(1-2):180-8
references: 8374776
references: Neurosci Lett. 1992 Aug 3;142(1):95-9
references: 1357611
references: Neuron. 2000 Dec;28(3):927-39
references: 11163277
references: J Neurophysiol. 1999 Dec;82(6):3575-9
references: 10601483
references: J Pharmacol Exp Ther. 1995 Jul;274(1):396-403
references: 7616424
references: J Anat. 2000 May;196 ( Pt 4):587-96
references: 10923989
references: Exp Neurol. 1997 Jul;146(1):142-50
references: 9225747
references: J Neurosci. 1995 Mar;15(3 Pt 1):1704-13
references: 7891129
references: Brain Res. 1995 Feb 20;672(1-2):104-11
references: 7749731
references: Eur Neuropsychopharmacol. 2000 Sep;10(5):365-75
references: 10974608
references: J Neurophysiol. 1995 Mar;73(3):1076-83
references: 7608756
references: Brain Res. 1990 Oct 8;529(1-2):30-41
references: 1980846
references: J Neurochem. 1999 Dec;73(6):2441-6
references: 10582604
references: Neurobiol Learn Mem. 1998 Jul-Sep;70(1-2):119-36
references: 9753592
references: Brain Res. 1993 Apr 9;608(1):123-8
references: 8495336
references: J Comp Neurol. 1999 Jun 21;409(1):38-56
references: 10363710
references: Neurochem Int. 1999 Jul;35(1):19-33
references: 10403427
references: Exp Neurol. 2000 Sep;165(1):191-206
references: 10964498
references: Trends Neurosci. 2007 May;30(5):211-9
references: 17367873
references: Neuroscience. 1996 Jan;70(1):1-5
references: 8848115
references: Gene Ther. 2003 Dec;10(26):2105-11
references: 14625564
references: Anal Chem. 1996 Sep 15;68(18):3180-6
references: 8797378
references: Prog Neurobiol. 2004 Dec;74(5):271-300
references: 15582223
references: Anal Chem. 2004 Oct 1;76(19):5697-704
references: 15456288
references: Nature. 2005 Oct 20;437(7062):1158-61
references: 16237445
references: J Neurophysiol. 2000 Sep;84(3):1422-9
references: 10980015
references: Eur J Neurosci. 1992;4(10):929-935
references: 12106428
references: J Neurosci. 1998 Jun 15;18(12):4732-43
references: 9614247
references: Nat Neurosci. 2004 Feb;7(2):105-10
references: 14747832
references: J Neurosci. 2000 Jun 15;20(12):4686-700
references: 10844038
references: Neurosci Lett. 1994 Nov 21;182(1):107-11
references: 7891873
references: Neuron. 2003 Sep 11;39(6):889-909
references: 12971891
references: Neuroscience. 1999 Jan;88(1):1-16
references: 10051185
references: J Neurosci Methods. 2002 Nov 15;121(1):41-52
references: 12393160
references: Trends Neurosci. 2004 Aug;27(8):460-7
references: 15271493
references: Neurochem Int. 2003 Dec;43(7):639-53
references: 12892651
references: J Neurosci. 2003 Nov 19;23(33):10585-92
references: 14627643
references: Trends Neurosci. 1990 Jul;13(7):254-8
references: 1695399
references: Neuroscience. 2005;132(3):741-54
references: 15837135
references: Exp Neurol. 2000 Jul;164(1):15-24
references: 10877911
references: Neurosci Lett. 1998 Aug 14;252(2):87-90
references: 9756328
references: Neuroscience. 2001;103(2):405-12
references: 11246155